Adagrasib (MRTX849)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 21:10, 26 December 2022 by Jwarner (talk | contribs) (Jwarner moved page Adagrasib (MRTX849) to Adagrasib (Krazati): FDA approval)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Redirect page
Jump to navigation Jump to search

Redirect to:

Retrieved from "https://hemonc.org/w/index.php?title=Adagrasib_(MRTX849)&oldid=65081"